Literature DB >> 22427181

Pasteurella multocida and immune cells.

Katharina F Kubatzky1.   

Abstract

Pasteurella multocida was first discovered by Perroncito in 1878 and named after Louis Pasteur who first isolated and described this Gram-negative bacterium as the cause of fowl disease in 1880. Subsequently, P. multocida was also found to cause atrophic rhinitis in pigs, haemorrhagic septicaemia in cattle and respiratory diseases in many other animals. Among other factors such as lipopolysaccharide, outer membrane proteins and its capsule, the protein toxin (PMT) of P. multocida is an important virulence factor that determines the immunological response of the host's immune system. However, the exact molecular mechanisms taking place in cells of the innate and adaptive immune system are largely unknown for any of these virulence factors. Due to the obvious function of PMT on cells of the porcine skeletal system where it causes bone destruction, PMT was regarded as an osteolytic protein toxin. However, it remained unclear what the actual benefit for the bacteria would be. Recently, more attention was drawn to the osteoimmunological effects of PMT and the interplay between bone and immune cells. This review summarises the knowledge of effects of P. multocida virulence factors on the host's immune system.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22427181     DOI: 10.1007/82_2012_204

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  13 in total

Review 1.  Pasteurella multocida: Genotypes and Genomics.

Authors:  Zhong Peng; Xiangru Wang; Rui Zhou; Huanchun Chen; Brenda A Wilson; Bin Wu
Journal:  Microbiol Mol Biol Rev       Date:  2019-09-04       Impact factor: 11.056

2.  Case Report: CD8+ T-Lymphocyte Deficit: A Prerequisite for Pasteurella spp. Infection?

Authors:  Eric Denes; Fabrice Fiorenza; Mateo Armendariz; Christian Martin
Journal:  Front Med (Lausanne)       Date:  2021-04-27

3.  Evaluation of Pasteurella multocida serotype B:2 resistance to immune serum and complement system.

Authors:  Saeed Ataei Kachooei; Mohammad Mehdi Ranjbar; Saba Ataei Kachooei
Journal:  Vet Res Forum       Date:  2017-09-15       Impact factor: 1.054

4.  Identification of an antilymphocyte transformation substance from Pasteurella multocida.

Authors:  Taishi Tanabe; Hiroki Fukuzawa; Yuki Amatatsu; Keigo Matsui; Hiromichi Ohtsuka; Yousuke Maeda; Hisaaki Sato
Journal:  Microbiol Immunol       Date:  2019-07-02       Impact factor: 1.955

Review 5.  Signaling cascades of Pasteurella multocida toxin in immune evasion.

Authors:  Katharina F Kubatzky; Bianca Kloos; Dagmar Hildebrand
Journal:  Toxins (Basel)       Date:  2013-09-24       Impact factor: 4.546

6.  Transcriptomic Analysis on Responses of Murine Lungs to Pasteurella multocida Infection.

Authors:  Chenlu Wu; Xiaobin Qin; Pan Li; Tingting Pan; Wenkai Ren; Nengzhang Li; Yuanyi Peng
Journal:  Front Cell Infect Microbiol       Date:  2017-06-20       Impact factor: 5.293

7.  Genetic and Phylogenetic Characteristics of Pasteurella multocida Isolates From Different Host Species.

Authors:  Zhong Peng; Wan Liang; Fei Wang; Zhuofei Xu; Zhihao Xie; Zhenghan Lian; Lin Hua; Rui Zhou; Huanchun Chen; Bin Wu
Journal:  Front Microbiol       Date:  2018-06-26       Impact factor: 5.640

8.  Isolation of a T7-Like Lytic Pasteurella Bacteriophage vB_PmuP_PHB01 and Its Potential Use in Therapy against Pasteurella multocida Infections.

Authors:  Yibao Chen; Guanghao Guo; Erchao Sun; Jiaoyang Song; Lan Yang; Lili Zhu; Wan Liang; Lin Hua; Zhong Peng; Xibiao Tang; Huanchun Chen; Bin Wu
Journal:  Viruses       Date:  2019-01-21       Impact factor: 5.048

9.  Peritonitis Secondary to Uncommon Gram-Negative Coccobacillus Transmitted From a Cat in a Patient on Peritoneal Dialysis.

Authors:  Sreedhar Adapa; Srikanth Naramala; Bhaskar Reddy Madhira; Vijay Gayam; Prem Sahasranam; Venu Madhav Konala
Journal:  J Investig Med High Impact Case Rep       Date:  2019 Jan-Dec

10.  [Septic shock and empyema induced by Pasteurella multocida].

Authors:  D Fernández Vecilla; M J Unzaga Barañano; C Aspichueta; J L Díaz de Tuesta
Journal:  Rev Esp Quimioter       Date:  2021-07-05       Impact factor: 1.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.